The production of the Covid-19 vaccine, Covaxin, will soon begin at Uttar Pradesh's Bulandshahr. It will manufacture 2 crore doses of Covaxin every month. Covaxxim manufacturer Bharat Biotech and BIBCOL have signed an MoU for the production of the vaccine at Bulandshahr plant. The company can manufacture 6 crore doses of polio vaccine per year with existing facilities.
In a meeting held on March 24, the Subject Expert Committee of the India drug regulator permitted Bharat Biotech to carry out a phase-2 trial of Covaxin wherein a booster dose is to be administered six months after the second dose to further improve vaccine efficacy. “The immunological principle says that to make long-lived antibody secreting cells as well as …
